Annual Total Long Term Liabilities
$0.00
$0.000.00%
30 September 2023
Summary:
Anavex Life Sciences annual total long term liabilities is currently $0.00, unchanged on 30 September 2023. During the last 3 years, it has risen by $0.00 (0.00%). AVXL annual total long term liabilities is now -100.00% below its all-time high of $5.72 million, reached on 30 September 2014.AVXL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
$0.000.00%
30 June 2024
Summary:
Anavex Life Sciences quarterly total long term liabilities is currently $0.00, unchanged on 30 June 2024. Over the past year, it has stayed the same.AVXL quarterly long term liabilities is now -100.00% below its all-time high of $5.72 million, reached on 30 September 2014.AVXL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVXL Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | 0.0% |
| 3 y3 years | 0.0% | 0.0% |
| 5 y5 years | 0.0% | 0.0% |
AVXL Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -100.0% | -100.0% |
Anavex Life Sciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | - | $0.00(0.0%) |
| Sept 2023 | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | - | $0.00(0.0%) |
| Sept 2022 | $0.00(0.0%) | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | - | $0.00(0.0%) |
| Sept 2021 | $0.00(0.0%) | $0.00(0.0%) |
| June 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | - | $0.00(0.0%) |
| Sept 2020 | $0.00(0.0%) | $0.00(0.0%) |
| June 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | - | $0.00(0.0%) |
| Sept 2019 | $0.00(0.0%) | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(0.0%) |
| Sept 2018 | $0.00(0.0%) | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | - | $0.00(0.0%) |
| Sept 2017 | $0.00(0.0%) | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | - | $0.00(0.0%) |
| Sept 2016 | $0.00 | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $300.00(0.0%) |
| Mar 2016 | - | $300.00(0.0%) |
| Dec 2015 | - | $300.00(0.0%) |
| Sept 2015 | $300.00(-100.0%) | $300.00(-99.5%) |
| June 2015 | - | $58.00 K(-56.6%) |
| Mar 2015 | - | $133.70 K(-97.4%) |
| Dec 2014 | - | $5.16 M(-9.8%) |
| Sept 2014 | $5.72 M(+532.7%) | $5.72 M(>+9900.0%) |
| June 2014 | - | $1100.00(+10.0%) |
| Mar 2014 | - | $1000.00(>+9900.0%) |
| Dec 2013 | - | $0.00(-100.0%) |
| Sept 2013 | $904.00 K(>+9900.0%) | $904.00 K(>+9900.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sept 2012 | $0.00(0.0%) | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sept 2011 | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sept 2010 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2010 | - | $963.40 K(-16.6%) |
| Mar 2010 | - | $1.16 M(+831.8%) |
| Dec 2009 | - | $124.00 K(-26.2%) |
| Sept 2009 | $168.00 K(>+9900.0%) | $168.00 K(>+9900.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | - | $0.00 |
| Sept 2004 | $0.00 | - |
FAQ
- What is Anavex Life Sciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly long term liabilities year-on-year change?
What is Anavex Life Sciences annual total long term liabilities?
The current annual total long term liabilities of AVXL is $0.00
What is the all time high annual total long term liabilities for Anavex Life Sciences?
Anavex Life Sciences all-time high annual total long term liabilities is $5.72 M
What is Anavex Life Sciences quarterly total long term liabilities?
The current quarterly long term liabilities of AVXL is $0.00
What is the all time high quarterly long term liabilities for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly total long term liabilities is $5.72 M
What is Anavex Life Sciences quarterly long term liabilities year-on-year change?
Over the past year, AVXL quarterly total long term liabilities has changed by $0.00 (0.00%)